Earnings Preview: Vericel to Report Financial Results on May 08
Vericel Shareholders Approve Key Proposals at Annual Meeting
Vericel Corp. (VCEL) Faces Challenges as Burn Care Revenue Wanes and MACI Growth Remains Uncertain
Shareholders Will Probably Hold Off On Increasing Vericel Corporation's (NASDAQ:VCEL) CEO Compensation For The Time Being
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
Are Vericel Corporation's (NASDAQ:VCEL) Mixed Financials Driving The Negative Sentiment?
Express News | Vericel Corp - Expects 100% Revenue From Domestic Sales in 2025 - SEC Filing
Express News | Vericel Corp - Anticipates Minimal Impact From New Tariffs - SEC Filing
BTIG Maintains Vericel(VCEL.US) With Buy Rating, Cuts Target Price to $60
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Cuts Target Price to $51
Is There An Opportunity With Vericel Corporation's (NASDAQ:VCEL) 47% Undervaluation?
BTIG Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $63
Vericel to Present at Multiple Upcoming Investor Conferences
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $61
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating
Truist Securities Cuts Price Target on Vericel to $61 From $67, Keeps Buy Rating
A Quick Look at Today's Ratings for Vericel(VCEL.US), With a Forecast Between $60 to $72
Analysts Offer Insights on Healthcare Companies: Vericel (VCEL), Radnet (RDNT) and Universal Health (UHS)
Truist Financial Remains a Buy on Vericel (VCEL)
Vericel Analyst Ratings